CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice

Diabetologia

Volumn 40, Issue 12, 1997, Pages 1476-1479

  Signore, A ^a,f   Annovazzi, A ^a   Procaccini, E ^a   Beales, P E ^b   Spencer, J ^c   Testi, R ^d   Ruberti, G ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e CNR   (Italy)

^f POLICLINICO UMBERTO I   (Italy)

Author keywords

Apoptosis; CD95; CD95L; NOD mouse

Indexed keywords

FAS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL DAMAGE; CELL DEATH; CONTROLLED STUDY; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD95; DIABETES MELLITUS, TYPE 1; FAS LIGAND PROTEIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOENZYME TECHNIQUES; ISLETS OF LANGERHANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, INBRED STRAINS;

EID: 0031465966     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050852     Document Type: Article

References (10)

1. Signore A, Pozzilli P, Gale EAM, Andreani D, Beverley PCL (1989) The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 32: 282-289
2. Chervosky AV, Wang Y, Wong FS et al. (1997) The role of Fas in autoimmune diabetes. Cell 89: 17-24
3. Kang SM, Schneider DB, Lin Z et al. (1997) Fas ligand expression in islets of Langerhans does not confer immune priviledge and instead targets them for rapid destruction. Nature Medicine 3: 738-743
4. Benoist C, Mathis D (1997) Cell death mediators in autoimmune diabetes - no shortage of suspects. Cell 89: 1-3
5. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
6. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632
7. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192
8. Lau HT, Yu M, Fontana A, Stoeckert CJ (1996) Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273: 109-112
9. Giordano C, Stassi G, De Maria Ret al. (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275: 960-963
10. Stassi G, Todaro M, Richiusa P et al. (1995) Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flow cytometry and cultured in vitro. Transplantation Proc 27: 1949